Edwards Life Sciences Corp. (EW): Today's Featured Health Care Loser

Edwards Life ( EW) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day up 0.5%. By the end of trading, Edwards Life fell $1.14 (-1.1%) to $102.10 on light volume. Throughout the day, 637,392 shares of Edwards Life exchanged hands as compared to its average daily volume of 1.1 million shares. The stock ranged in price between $101.86-$103.37 after having opened the day at $102.67 as compared to the previous trading day's close of $103.24. Other company's within the Health Care sector that declined today were: Natural Alternatives International ( NAII), down 18.4%, StemCells ( STEM), down 17.2%, Anthera Pharmaceuticals ( ANTH), down 16.9%, and MEI Pharma ( MEIP), down 12.8%.

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases or critically ill patients worldwide. Edwards Life has a market cap of $11.62 billion and is part of the health services industry. The company has a P/E ratio of 49.7, below the average health services industry P/E ratio of 51 and above the S&P 500 P/E ratio of 17.7. Shares are up 43.5% year to date as of the close of trading on Tuesday. Currently there are nine analysts that rate Edwards Life a buy, no analysts rate it a sell, and eight rate it a hold.

TheStreet Ratings rates Edwards Life as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, Somaxon Pharmaceuticals ( SOMX), up 61.5%, Supernus Pharmaceuticals ( SUPN), up 37%, ADVENTRX Pharmaceuticals ( ANX), up 19.1%, and Cormedix ( CRMD), up 17.3%, were all gainers within the health care sector with Celgene Corporation ( CELG) being today's featured health care sector winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Edwards Lifesciences: Cramer's Top Takeaways

Don't Let Stock Picking Scare You: Cramer's 'Mad Money' Recap (Wednesday 7/19/17)

Hold on Concert's Hair Loss Trials Pushes Shares Down 10%

Edwards Lifesciences Is Not Skipping A Beat

Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock